Varta
← Back to stories

From The Hindu BusinessLine

Center-Right Owned by The Hindu Group (Kasturi & Sons)

NPPA exempts Biodeal’s indigenously developed midazolam nasal spray from price control for five years

NPPA exempts Biodeal’s indigenously developed midazolam nasal spray from price control for five years

RSS excerpt

Midazolam 1.25 per cent w/v nasal spray is a prescription rescue medicine used primarily for the emergency treatment of acute repetitive seizures

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →